Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Applebaum

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
NPJ Precision Oncology|February 11, 2026
5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcomaEvan W Neczypor, Hailey Reisert, Kelley Moore, et al.
JAMA Network Open|July 8, 2021
Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk NeuroblastomaSkye Balyasny, Sang Mee Lee, Ami V Desai, et al.
Cancer Research Communications|August 5, 2024
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic SignaturesMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signatureMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
5-hydroxymethylcytosine deposition mediates Polycomb Repressive Complex 2 function in <i>MYCN</i> -amplified neuroblastomaMohansrinivas Chennakesavalu, Gabriel L Lopez, Varsha Gupta, et al.
Clinical and Translational Science|February 22, 2026
Hypoxia Promotes an Adrenergic to Mesenchymal Transcriptional Program Transition in NeuroblastomaGepoliano S Chaves, Mohansrinivas Chennakesavalu, Kelley Moore, et al.
EJC Paediatric Oncology|January 12, 2024
Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two DecadesMohansrinivas Chennakesavalu, Caileigh Pudela, Mark A Applebaum, et al.
Molecular Cancer Therapeutics|January 25, 2019
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for NeuroblastomaAlexandre Chlenski, Chanyoung Park, Marija Dobratic, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 21, 2023
Histotripsy induces apoptosis and reduces hypoxia in a neuroblastoma xenograft modelIsabella Iwanicki, Lydia L Wu, Fernando Flores-Guzman, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Histotripsy-initiated immune response synergizes with chemotherapy in a neuroblastoma murine modelNatalia Antonides-Jensen, Muskan Singh, Yuqing Xue, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
NPJ Precision Oncology|February 11, 2026
5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcomaEvan W Neczypor, Hailey Reisert, Kelley Moore, et al.
JAMA Network Open|July 8, 2021
Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk NeuroblastomaSkye Balyasny, Sang Mee Lee, Ami V Desai, et al.
Cancer Research Communications|August 5, 2024
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic SignaturesMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signatureMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
5-hydroxymethylcytosine deposition mediates Polycomb Repressive Complex 2 function in <i>MYCN</i> -amplified neuroblastomaMohansrinivas Chennakesavalu, Gabriel L Lopez, Varsha Gupta, et al.
Clinical and Translational Science|February 22, 2026
Hypoxia Promotes an Adrenergic to Mesenchymal Transcriptional Program Transition in NeuroblastomaGepoliano S Chaves, Mohansrinivas Chennakesavalu, Kelley Moore, et al.
EJC Paediatric Oncology|January 12, 2024
Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two DecadesMohansrinivas Chennakesavalu, Caileigh Pudela, Mark A Applebaum, et al.
Molecular Cancer Therapeutics|January 25, 2019
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for NeuroblastomaAlexandre Chlenski, Chanyoung Park, Marija Dobratic, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 21, 2023
Histotripsy induces apoptosis and reduces hypoxia in a neuroblastoma xenograft modelIsabella Iwanicki, Lydia L Wu, Fernando Flores-Guzman, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Histotripsy-initiated immune response synergizes with chemotherapy in a neuroblastoma murine modelNatalia Antonides-Jensen, Muskan Singh, Yuqing Xue, et al.
Pageof 7